Oragenics, Inc.

Oragenics, Inc. - PE Ratioverified

OGEN

Price:

$0.5494

Market Cap:

$2.48M

Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also has other experimental treatments under development, including LPT3-04, targeting weight loss, and SMaRT Replacement Therapy, a topical solution aimed at preventing dental cavities. Strategic alliances are also a part of its operations. This includes a licensing deal with Noachis Terra Inc. for patent...[Read more]

Industry

Biotechnology

IPO Date

2004-02-25

Stock Exchange

AMEX

Ticker

OGEN

The PE Ratio as of June 2026 (TTM) for Oragenics, Inc. (OGEN) is -0.11

According to Oragenics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -60.44% compared to the average of -0.28 of the last 4 quarters.

Oragenics, Inc. (OGEN) Historical PE Ratio (quarterly & annually)

How has OGEN PE Ratio performed in the past?

The mean historical PE Ratio of Oragenics, Inc. over the last ten years is -41.12. The current -0.11 PE Ratio has changed -73.25% with respect to the historical average. Over the past ten years (40 quarters), OGEN's PE Ratio was at its highest in in the September 2025 quarter at -0.17. The PE Ratio was at its lowest in in the June 2016 quarter at -490.38.

Quarterly (TTM)
Annual

Average

-41.12

Median

-31.35

Minimum

-103.02

Maximum

-0.17

Oragenics, Inc. (OGEN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Oragenics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 244.41%

Maximum Annual PE Ratio = -0.17

Minimum Annual Increase = -97.52%

Minimum Annual PE Ratio = -103.02

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.17-97.52%
2024-6.92-62.36%
2023-18.40-30.85%
2022-26.61-73.19%
2021-99.23244.41%
2020-28.81-32.36%
2019-42.6025.71%
2018-33.89-34.29%
2017-51.57-49.94%
2016-103.02-26.74%

Oragenics, Inc. (OGEN) Average PE Ratio

How has OGEN PE Ratio performed in the past?

The current PE Ratio of Oragenics, Inc. (OGEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-8.50

5-year avg

-30.27

10-year avg

-41.12

Oragenics, Inc. (OGEN) PE Ratio vs. Peers

How is OGEN’s PE Ratio compared to its peers?

Oragenics, Inc.’s PE Ratio is greater than AIM ImmunoTech Inc. (-0.21), greater than KALA BIO, Inc. (-1.25), less than Ensysce Biosciences, Inc. (-0.08), greater than Soligenix, Inc. (-0.20), greater than Qualigen Therapeutics, Inc. (-0.14), greater than Can-Fite BioPharma Ltd. (-685.88), greater than Xenetic Biosciences, Inc. (-2.28), greater than CNS Pharmaceuticals, Inc. (-0.16), greater than Kazia Therapeutics Limited (-1.91), less than Titan Pharmaceuticals, Inc. (13.82),

Build a custom stock screener for Oragenics, Inc. (OGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oragenics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oragenics, Inc. (OGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oragenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Oragenics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Oragenics, Inc. (OGEN)?

What is the highest PE Ratio for Oragenics, Inc. (OGEN)?

What is the 3-year average PE Ratio for Oragenics, Inc. (OGEN)?

What is the 5-year average PE Ratio for Oragenics, Inc. (OGEN)?

How does the current PE Ratio for Oragenics, Inc. (OGEN) compare to its historical average?